Cosmo Highlights Real-Time Medical AI at NVIDIA GTC

Cosmo presents its approach to designing and deploying artificial intelligence systems for clinical environments.

Mar. 16, 2026 at 6:09am

Got story updates? Submit your updates here. ›

Cosmo Pharmaceuticals, a life sciences company focused on MedTech AI, announced its participation at NVIDIA GTC 2026, the world's leading conference for artificial intelligence and accelerated computing. At the conference, Cosmo will present a technical session titled 'Engineering Medical Grade Platforms for Real Time AI', highlighting the company's approach to designing and deploying artificial intelligence systems for use in clinical environments.

Why it matters

Cosmo's presentation at NVIDIA GTC reflects the company's continued commitment to advancing artificial intelligence in healthcare and strengthening its position at the intersection of medical technology and AI. The session will explore the engineering challenges behind building medical grade AI platforms capable of operating in real time during medical procedures.

The details

Cosmo develops real-time artificial intelligence systems designed to operate during medical procedures, assisting physicians with detection, decision support, and workflow optimization. Through platforms such as GI Genius, Cosmo has demonstrated how AI can move beyond research and deliver measurable value in everyday clinical practice. Cosmo's engineering teams leverage advanced accelerated computing technologies from NVIDIA to develop these AI systems.

  • The NVIDIA GTC 2026 conference is taking place from March 16 to March 19 in San Jose, California.
  • Cosmo's technical session 'Engineering Medical Grade Platforms for Real Time AI' will be delivered on Thursday, March 19 from 10:00 to 10:50 CET.

The players

Cosmo Pharmaceuticals N.V.

A life sciences company focused on MedTech AI, dermatology, gastrointestinal diseases, and contract development and manufacturing (CDMO). The company designs, develops, and manufactures advanced solutions that address critical medical needs and raise the standard of care.

Nhan Ngo Dinh

President of MedTech AI at Cosmo.

Pietro Salvagnini

Director of AI Factory at Cosmo.

Giovanni Di Napoli

CEO of Cosmo Pharmaceuticals N.V.

NVIDIA

A technology company that specializes in the design and manufacture of graphics processing units (GPUs) and related technologies.

Got photos? Submit your photos here. ›

What they’re saying

“Artificial intelligence will fundamentally reshape medicine. At Cosmo, we are focused on building medical grade AI systems that operate in real clinical environments and support physicians during procedures. Presenting our work at NVIDIA GTC reflects the progress our teams are making in bringing AI from research into everyday medical practice.”

— Giovanni Di Napoli, CEO of Cosmo Pharmaceuticals N.V.

The takeaway

Cosmo's presentation at NVIDIA GTC highlights the company's commitment to advancing artificial intelligence in healthcare and its efforts to develop real-time AI systems that can be deployed in clinical environments to assist physicians during medical procedures.